BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34646402)

  • 1. Genetic Polymorphisms of
    Chen L; Chen J; Mo F; Bian Z; Jin C; Chen X; Liang C
    Dis Markers; 2021; 2021():2898336. PubMed ID: 34646402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of IFNG and IFNGR1 in association with the risk of pulmonary tuberculosis.
    Lü J; Pan H; Chen Y; Tang S; Feng Y; Qiu S; Zhang S; Wu L; Xu R; Peng X; Wang J; Lu C
    Gene; 2014 Jun; 543(1):140-4. PubMed ID: 24680779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
    Franco JV; Turk T; Jung JH; Xiao YT; Iakhno S; Garrote V; Vietto V
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012551. PubMed ID: 29757454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Polymorphisms of
    Wu S; Liu X; Wang Y; Zhang M; Wang M; He JQ
    Dis Markers; 2019; 2019():8410290. PubMed ID: 31687049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
    Franco JV; Turk T; Jung JH; Xiao YT; Iakhno S; Garrote V; Vietto V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012551. PubMed ID: 29372565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk factors related to the severity of pain in patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
    Chen J; Zhang H; Niu D; Li H; Wei K; Zhang L; Yin S; Liu L; Zhang X; Zhang M; Liang C
    BMC Urol; 2020 Oct; 20(1):154. PubMed ID: 33028277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel susceptibility factors related to CP/CPPS-like symptoms: Evidence from a multicenter case-control study.
    Zhang M; Jin C; Kong X; Meng J; Fan S; Ding Y; Fang Q; Dong T; Zhang H; Ni J; Liu Y; Wang H; Chen X; Hao Z; Peng B; Zhang L; Wang Z; Liang C
    Prostate; 2022 May; 82(7):772-782. PubMed ID: 35188987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
    Franco JV; Turk T; Jung JH; Xiao YT; Iakhno S; Tirapegui FI; Garrote V; Vietto V
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD012552. PubMed ID: 31587256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.
    Wagenlehner FM; van Till JW; Magri V; Perletti G; Houbiers JG; Weidner W; Nickel JC
    Eur Urol; 2013 May; 63(5):953-9. PubMed ID: 23141933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.
    Zhang Y; Zheng T; Tu X; Chen X; Wang Z; Chen S; Yang Q; Wan Z; Han D; Xiao H; Sun X; Deng C
    PLoS One; 2016; 11(4):e0153054. PubMed ID: 27120096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study on association of prostatic calcifications with sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
    Zhao Z; Xuan X; Zhang J; He J; Zeng G
    J Sex Med; 2014 Oct; 11(10):2528-36. PubMed ID: 24735240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.
    Schneider H; Brähler E; Ludwig M; Hochreiter W; Collins MF; Eremenco S; Weidner W
    Urology; 2004 Jun; 63(6):1027-30. PubMed ID: 15183940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary evaluation of the psychometric profiles in Chinese men with chronic prostatitis/chronic pelvic pain syndrome.
    Zhang GX; Bai WJ; Xu T; Wang XF
    Chin Med J (Engl); 2011 Feb; 124(4):514-8. PubMed ID: 21362273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.
    Walz J; Perrotte P; Hutterer G; Suardi N; Jeldres C; Bénard F; Valiquette L; Karakiewicz PI
    BJU Int; 2007 Dec; 100(6):1307-11. PubMed ID: 17941922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in IFNG and IFNGR1 and tuberculosis susceptibility.
    Wu S; Wang Y; Zhang M; Wang M; He JQ
    Cytokine; 2019 Nov; 123():154775. PubMed ID: 31310896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of functional SNP in ifng/ifngr1 in Chinese Han population with tuberculosis.
    He J; Wang J; Lei D; Ding S
    Scand J Immunol; 2010 Jun; 71(6):452-8. PubMed ID: 20500698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D; Wang P; Chen J; Wang S; Jiang H
    Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between premature ejaculation and chronic prostatitis/chronic pelvic pain syndrome.
    Lee JH; Lee SW
    J Sex Med; 2015 Mar; 12(3):697-704. PubMed ID: 25475760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X Chromosomal short tandem repeat polymorphisms near the phosphoglycerate kinase gene in men with chronic prostatitis.
    Riley DE; Krieger JN
    Biochim Biophys Acta; 2002 Jan; 1586(1):99-107. PubMed ID: 11781154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-control study on the association between chronic prostatitis/chronic pelvic pain syndrome and erectile dysfunction.
    Chung SD; Keller JJ; Lin HC
    BJU Int; 2012 Sep; 110(5):726-30. PubMed ID: 22313519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.